Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET-study in haloperidol-treated patients

Psychiatry Research - Neuroimaging

Volumn 67, Issue 3, 1996, Pages 163-171

  Nyberg, Svante ^a   Farde, Lars ^a   Halldin, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

haloperidol; human; positron emission tomography; schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL; RACLOPRIDE;

ADULT; ARTICLE; CASE REPORT; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SCHIZOPHRENIA;

EID: 0030574074     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4927(96)02921-6     Document Type: Article

References (28)

1. Baron, J.C., Martinot, J.L., Cambon, H., Boulenger, J.P., Poirier, M.F., Caillard, V., Blin, J., Huret, J.D., Loc'h, C. and Mazière, B. (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99, 463-472.
2. Bergström, M., Boëthius, J., Eriksson, L., Greitz, T., Ribbe, T. and Widén, L. (1981) Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 5, 136-141.
3. Burt, D., Creese, I. and Snyder, S. (1977) Antischizophrenic drugs: Chronic treatment elevated dopamine receptor binding in brain. Science 196, 326-328.
4. Clow, A., Theodorou, A. and Jenner, P. (1980) Changes in rat striatal dopamine turnover and receptor activity during one year's neuroleptic administration. Eur J Pharmacol 63, 135-144.
5. 11C]raclopride binding to D2-dopamine receptors studied by PET - A comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9, 696-708.
6. Farde, L., Hall, H., Ehrin, E. and Sedvall, G. (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231, 258-261.
7. 11C]raclopride in man. Synapse 20, 200-208.
8. 2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine - relation to extrapyramidal side effects. Arch Gen Psychiatry 49, 538-544.
9. 11C-raclopride in living human brain a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 94, 471-478.
10. Farde, L., Wiesel, F.-A., Halldin, C. and Sedvall, G. (1988b) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45, 71-76.
11. 2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 47, 213-219.
12. Guy, W. (1976) Clinical Global Impressions. In: ECDEU Assessment Manual for Psychopharmacology, revised (DHEW Publication No. [ADM] 76-338). Superintendent of Documents, U.S. Government Printing Office, Washington, DC.
13. Halldin, C., Farde, L., Högberg, T., Hall, H., Ström, P., Ohlberger, A. and Solin, O. (1991) A comparative PET-study of five carbon-11 or fluorine-18 labelled salicy-lamides. Preparation and in vitro dopamine D-2 binding. lnt J Rad Appl Instrum [B] 18, 871-881.
14. Kingsley, D., Bergström, M. and Berggren, B.-M. (1980) A critical evaluation of two methods of head fixation. Neuroradiology 19, 7-12.
15. Litton, J.E., Holte, S. and Eriksson, L. (1990) Evaluation of the Karolinska new positron camera system; the Scanditronix PC2048-15B. IEEE Trans Nucl Sci 37, 743-748.
16. Llerena, A., Alm, C., Dahl M-L, Ekqvist, B. and Bertilsson, L. (1992) Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype. Ther Drug Monit 14, 92-47.
17. Nayak, R.K., Doose, D.R. and Nair, N.P.V. (1987) The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients. J Clin Pharmacol 27, 144-150.
18. 11C]N-methylspiperone. Psychiatry Res Neuroimaging 61, 67-83.
19. 11C]raclopride binding in healthy young adults and schizophrenic patients - reliability and age effects. Hum Psychopharmacol 7, 157-165.
20. Nordström, A.-L., Farde, L., Wiesel, F.-A., Forslund, K., Pauli, S., Halldin, C. and Uppfeldt, G. (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects - a double blind PET study of schizophrenic patients. Biol Psychiatry 33, 227-235.
21. 2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Am J Psychiatry 152, 173-178.
22. Nyberg, S., Nordström, A.-L., Halldin, C. and Farde, L. (1995b) PET studies on D2 dopamine receptor occupancy and antipsychotic drug plasma levels in man. Int Clin Psychopharmacology 10 (Suppl. 3), 81-85.
23. 3H-spiperone binding to striatal membranes in rats after nine months' haloperidol administration. Life Sci 26, 55-59.
24. Reyntjens, A.J.M., Heykants, J.J.P., Woestenborghs, R.J.H., Gelders, Y.G. and Aerts, T.J.L. (1982) Pharmacokinetics of haloperidol decanoate. A 2-year follow-up. Int Pharmacopsychiatry 17, 238-246.
25. 11C]raclopride. J Cereb Blood Flow Metab 13, 310-314.
26. Sedvall, G., Farde, L., Persson, A. and Wiesel, F.-A. (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43, 995-1005.
27. Volkow, N.D., Fowler, J.S., Wang, G.J., Dewey, S.L., Schlyer, D., MacGregor, R., Logan, J., Alexoff, D., Shea, C., Hitzemann, R., Angrist, B. and Wolf, A. (1993) Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 34, 609-13.
28. Wagner, H.N., Jr. Burns, H.D., Dannals, R.F., Wong, D.F., Långström, B., Duelfer, T., Frost, J.J., Ravert, H.T., Links, J.M., Rosenbloom, S.B., Lukas, S.E., Kramer, A.V. and Kuhar, M.J. (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221, 1264-1266.